Community-based delivery of HIV treatment in Zambia: costs and outcomes

OBJECTIVE:To determine the total annual cost per patient treated and total cost per patient retained on antiretroviral therapy in Zambia in conventional care in facilities and across community-based differentiated service delivery (DSD) models. DESIGN:Economic evaluation using retrospective electron...

Full description

Saved in:
Bibliographic Details
Published inAIDS (London) Vol. 35; no. 2; pp. 299 - 306
Main Authors Nichols, Brooke E, Cele, Refiloe, Jamieson, Lise, Long, Lawrence C, Siwale, Zumbe, Banda, Patrick, Moyo, Crispin, Rosen, Sydney
Format Journal Article
LanguageEnglish
Published England Copyright Wolters Kluwer Health, Inc 02.02.2021
Lippincott Williams & Wilkins
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:OBJECTIVE:To determine the total annual cost per patient treated and total cost per patient retained on antiretroviral therapy in Zambia in conventional care in facilities and across community-based differentiated service delivery (DSD) models. DESIGN:Economic evaluation using retrospective electronic record review. SETTING:Twenty healthcare facilities (13 with DSD models and 7 as comparison sites) in 6 of Zambiaʼs 10 provinces. SUBJECTS, PARTICIPANTS:All individuals on ART > 18 years old at the study sites, enrolled in a DSD model or conventional care by site type, respectively, with at least 12 months of follow-up data. INTERVENTION:Accessing care through DSD models (community adherence groups (CAGs), urban adherence groups (UAGs), home ART delivery and care, and mobile ART services) or facility-based conventional care with 3-monthly visits. MAIN OUTCOME MEASURES:Total annual cost per patient treated and annual cost per patient retained in care 12 months after model enrolment. Retention in care was defined as attending a clinic visit at 12 months +/- 3 months. RESULTS:The DSD models assessed cost more per patient/year than conventional care. Costs ranged from an annual $116 to $199 for the DSD models, compared with $100 for conventional care. CAGs and UAGs increased retention by 2% and 14%, respectively. All DSD models cost more per patient retained at 12 months than conventional care. The CAG had the lowest cost/patient retained for DSD models ($140–157). CONCLUSIONS:Though they achieve equal or improved retention in care, out-of-facility models of ART were more expensive than conventional care.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0269-9370
1473-5571
DOI:10.1097/QAD.0000000000002737